Frontier Capital Management’s Biogen BIIB Stock Holding History

Frontier Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,000	Closed	-$939K	–	329
2016 Q3	$939K	Sell	3,000 -446	-13%	-$132K	0.01%	293
2016 Q2	$833K	Sell	3,446 -331	-9%	-$87.2K	0.01%	296
2016 Q1	$983K	Sell	3,777 -500	-12%	-$132K	0.01%	300
2015 Q4	$1.31M	Sell	4,277 -2,726	-39%	-$783K	0.01%	307
2015 Q3	$2.04M	Buy	7,003 +1,760	+34%	+$581K	0.02%	304
2015 Q2	$2.12M	Buy	5,243 +1,899	+57%	+$762K	0.02%	311
2015 Q1	$1.41M	Buy	+3,344	New	+$1.32M	0.01%	320

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Frontier Capital Management's BIIB Position: Q4 2016 in Review

Frontier Capital Management sold out of Biogen (BIIB) in Q4 2016, closing a stake of 3,000 shares — an estimated $939K sold.

Frontier Capital Management first reported a position in BIIB in Q1 2015 and held it in 7 quarters. The position peaked at $2.12M in Q2 2015. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

Frontier Capital Management reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
Frontier Capital Management sold 3,000 Biogen shares in Q4 2016, an estimated $939K.
Frontier Capital Management first reported a position in Biogen in Q1 2015 and held it in 7 quarters.
Frontier Capital Management's Biogen position peaked at $2.12M in Q2 2015.
1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on Frontier Capital Management's 13F filing for Q4 2016, filed 3 Feb 2017.